RDNT RadNet, Inc.
Stock · NasdaqGM · United States · Healthcare · US7504911022
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by RadNet, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
76.00 USD
-2.58%
52-week range
50.82 – 85.84
Dividend yield—
Market cap6.1B
NowoTrade score
33 Grade A
Price history
Daily prices in USD.
Updated 06 Nov 2026 21:06. Information, not advice.
Results
Next results
08 Nov 2026
in 1 days · 16:00 · estimate 0.22
Last results
0.29 vs 0.20 estimated
09 Aug 2026 · Beat +44.0%
Beat the estimate
8 of 12
4 missed · 0 in line
Average surprise
+115.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 08 Nov 2026 16:00 | 0.22 | — | — | Upcoming |
| 09 Aug 2026 16:00 | 0.20 | 0.29 | +44.0% | Beat |
| 10 May 2026 16:00 | -0.19 | -0.28 | -46.1% | Miss |
| 02 Mar 2026 06:00 | 0.20 | 0.23 | +12.6% | Beat |
| 09 Nov 2025 16:00 | 0.23 | 0.20 | -11.8% | Miss |
| 10 Aug 2025 16:00 | 0.16 | 0.31 | +97.9% | Beat |
| 11 May 2025 16:00 | -0.13 | -0.35 | -166.8% | Miss |
| 27 Feb 2025 16:00 | 0.19 | 0.22 | +17.3% | Beat |
| 10 Nov 2024 16:00 | 0.17 | 0.18 | +5.9% | Beat |
| 07 Aug 2024 16:00 | 0.17 | 0.16 | -8.1% | Miss |
| 08 May 2024 16:00 | 0.01 | 0.07 | +1,300.0% | Beat |
| 29 Feb 2024 16:00 | 0.13 | 0.20 | +56.3% | Beat |
| 08 Nov 2023 16:00 | 0.07 | 0.14 | +89.2% | Beat |
| 08 Aug 2023 06:00 | 0.10 | 0.24 | +152.6% | Beat |
| 09 May 2023 06:00 | -0.08 | -0.08 | 0.0% | In line |
| 01 Mar 2023 14:00 | 0.15 | 0.11 | -25.0% | Miss |
| 09 Nov 2022 06:00 | 0.16 | 0.09 | -43.0% | Miss |
| 09 Aug 2022 06:00 | 0.09 | 0.15 | +71.4% | Beat |
| 09 May 2022 06:00 | — | -0.15 | -4,604.5% | Miss |
| 01 Mar 2022 06:00 | 0.19 | 0.13 | -30.7% | Miss |
| 08 Nov 2021 06:00 | 0.18 | 0.21 | +18.3% | Beat |
| 09 Aug 2021 06:00 | 0.14 | 0.27 | +88.4% | Beat |
| 10 May 2021 06:00 | -0.04 | 0.04 | +209.1% | Beat |
| 08 Mar 2021 06:00 | 0.15 | 0.20 | +36.4% | Beat |
| 09 Nov 2020 06:00 | -0.12 | 0.15 | +225.0% | Beat |
| 10 Aug 2020 16:00 | -0.51 | -0.14 | +72.6% | Beat |
| 11 May 2020 12:00 | -0.29 | -0.31 | -6.9% | Miss |
| 12 Mar 2020 06:00 | 0.15 | 0.21 | +43.2% | Beat |
| 12 Nov 2019 06:00 | 0.12 | 0.08 | -34.6% | Miss |
| 09 Aug 2019 13:00 | 0.14 | 0.10 | -22.6% | Miss |
| 09 May 2019 06:00 | -0.06 | -0.06 | +7.3% | Beat |
| 14 Mar 2019 06:00 | 0.18 | 0.37 | +105.7% | Beat |
| 09 Nov 2018 06:00 | 0.16 | 0.10 | -36.4% | Miss |
| 09 Aug 2018 06:00 | 0.14 | 0.12 | -13.3% | Miss |
| 09 May 2018 06:00 | -0.07 | -0.14 | -104.3% | Miss |
| 08 Mar 2018 06:00 | 0.13 | 0.13 | +4.0% | Beat |
| 09 Nov 2017 06:00 | 0.12 | 0.12 | 0.0% | In line |
| 08 Aug 2017 06:00 | 0.04 | 0.10 | +145.0% | Beat |
| 10 May 2017 06:00 | 0.01 | -0.03 | -400.0% | Miss |
| 14 Mar 2017 06:00 | 0.11 | 0.11 | +2.4% | Beat |
| 09 Nov 2016 06:00 | 0.12 | 0.11 | -8.3% | Miss |
| 09 Aug 2016 06:00 | 0.05 | 0.09 | +100.0% | Beat |
| 10 May 2016 08:00 | -0.04 | -0.04 | 0.0% | In line |
| 14 Mar 2016 06:00 | 0.17 | 0.04 | -75.3% | Miss |
| 09 Nov 2015 06:00 | 0.18 | 0.12 | -30.7% | Miss |
| 10 Aug 2015 06:00 | 0.13 | 0.08 | -40.0% | Miss |
| 11 May 2015 06:00 | 0.06 | -0.11 | -289.5% | Miss |
| 16 Mar 2015 06:00 | 0.08 | 0.10 | +24.4% | Beat |
| 06 Nov 2014 06:00 | 0.05 | 0.10 | +89.6% | Beat |
| 08 Aug 2014 06:00 | 0.05 | 0.14 | +171.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2B | +11.5% | -18.7M | -0.9% | -0.25 | -725.0% | 85.6M |
| 2024 | 1.8B | +13.2% | 2.8M | 0.2% | 0.04 | -20.0% | 45M |
| 2023 | 1.6B | +13.0% | 3M | 0.2% | 0.05 | -70.6% | 44.3M |
| 2022 | 1.4B | — | 10.7M | 0.7% | 0.17 | — | 27M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 29 Feb 2024 | 37.88 | 38.31 | 37.04 | 37.86 | +0.88% | 569,200 | |
| 28 Feb 2024 | 38.10 | 38.21 | 36.47 | 37.53 | -2.11% | 478,100 | |
| 27 Feb 2024 | 38.68 | 38.68 | 38.21 | 38.34 | -0.93% | 235,900 | |
| 26 Feb 2024 | 38.65 | 39.55 | 38.65 | 38.70 | +0.13% | 468,500 | |
| 23 Feb 2024 | 39.19 | 39.19 | 38.23 | 38.65 | -0.77% | 265,300 | |
| 22 Feb 2024 | 38.58 | 39.13 | 38.19 | 38.95 | +1.14% | 311,100 | |
| 21 Feb 2024 | 37.47 | 38.55 | 37.21 | 38.51 | +2.12% | 315,100 | |
| 20 Feb 2024 | 37.99 | 38.37 | 36.96 | 37.71 | -1.51% | 331,800 | |
| 16 Feb 2024 | 38.38 | 38.84 | 37.81 | 38.29 | -0.73% | 234,900 | |
| 15 Feb 2024 | 39.00 | 39.32 | 38.27 | 38.57 | -0.10% | 298,500 | |
| 14 Feb 2024 | 38.45 | 38.87 | 37.80 | 38.61 | +3.04% | 213,600 | |
| 13 Feb 2024 | 38.00 | 38.65 | 37.22 | 37.47 | -3.13% | 409,000 | |
| 12 Feb 2024 | 38.18 | 39.01 | 38.09 | 38.68 | +2.60% | 485,200 | |
| 09 Feb 2024 | 35.82 | 37.75 | 35.69 | 37.70 | +5.40% | 278,900 | |
| 08 Feb 2024 | 35.67 | 36.03 | 35.16 | 35.77 | +0.20% | 307,900 | |
| 07 Feb 2024 | 37.21 | 37.21 | 35.46 | 35.70 | -3.59% | 524,400 | |
| 06 Feb 2024 | 36.98 | 37.38 | 36.80 | 37.03 | -0.32% | 160,100 | |
| 05 Feb 2024 | 37.19 | 37.60 | 36.96 | 37.15 | -1.35% | 209,200 | |
| 02 Feb 2024 | 37.76 | 38.10 | 37.12 | 37.66 | -1.44% | 204,100 | |
| 01 Feb 2024 | 37.24 | 38.28 | 36.84 | 38.21 | +3.35% | 204,400 | |
| 31 Jan 2024 | 37.69 | 38.07 | 36.77 | 36.97 | -1.96% | 429,400 | |
| 30 Jan 2024 | 37.91 | 38.26 | 37.38 | 37.71 | -1.05% | 282,500 | |
| 29 Jan 2024 | 37.20 | 38.16 | 36.97 | 38.11 | +2.28% | 202,600 | |
| 26 Jan 2024 | 37.12 | 37.71 | 36.74 | 37.26 | +0.87% | 293,300 | |
| 25 Jan 2024 | 38.38 | 38.43 | 36.51 | 36.94 | -2.07% | 353,400 |
Page 28 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- RadNet (RDNT) Benefits from Rising Demand for Advanced Imaging (opens in a new tab) Insider Monkey · 05 Nov 2026 16:29
- RadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (opens in a new tab) Zacks · 05 Nov 2026 13:15
- RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock? (opens in a new tab) Zacks · 05 Nov 2026 08:20
- RadNet (RDNT) Stock Looks Priced At A Premium After ONRAD Deal (opens in a new tab) Simply Wall St. · 05 Nov 2026 01:09
- RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth (opens in a new tab) Zacks · 02 Nov 2026 14:00
- 3 Reasons to avoid RDNT and 1 stock to buy instead (opens in a new tab) StockStory · 28 Oct 2026 22:46
- RadNet expands into teleradiology with $350M Onrad deal (opens in a new tab) MedTech Dive · 28 Oct 2026 14:00
- RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services (opens in a new tab) MarketBeat · 28 Oct 2026 00:04
- RadNet acquires ONRAD in $355m deal to broaden radiology provision (opens in a new tab) Medical Device Network · 27 Oct 2026 12:36
- What RadNet (RDNT) Earnings Beat Means For Shareholders (opens in a new tab) Simply Wall St. · 17 Oct 2026 09:12
- Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks (opens in a new tab) StockStory · 08 Oct 2026 18:44
- RadNet (RDNT) Stock May Be 23% Below Fair Value On Cash Flow (opens in a new tab) Simply Wall St. · 15 Sep 2026 03:09
- RadNet (RDNT) Posts Record Revenue But Profit Growth Lags (opens in a new tab) Insider Monkey · 04 Sep 2026 10:58
- RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised (opens in a new tab) Zacks · 11 Aug 2026 16:20
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 78.01 USD
- Market cap
- 6.1B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 21.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 8.3 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 6.3 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.3 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 50: three or more warnings
- Heavy debt: net debt is 5.3× EBITDA
- Thin interest cover: operating profit is only 1.2× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 92.68× | Weak | 14.98× |
| Price / book | 5.45× | Weak | 3.87× |
| Price / sales | 2.64× | Fair | 3.42× |
| EV / EBITDA | 28.59× | Weak | 13.09× |
| Free cash flow yield | 2.6% | Fair | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 17.3% | Weak | 59.2% |
| Operating margin | 7.9% | Weak | 7.8% |
| Net margin | -0.9% | Weak | 3.4% |
| Return on equity | 1.5% | Weak | 5.7% |
| Return on assets | 1.7% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 12.6% | Good | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.57× | Fair | 0.46× |
| Net debt / EBITDA | 5.28× | Weak | 1.48× |
| Interest cover | 1.19× | Weak | 3.26× |
| Current ratio | 1.48× | Fair | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow RDNT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.